| Dr Disha Geriani, MD | |
|
4100 Lake Dr Se Ste 200, Grand Rapids, MI 49546-8292 | |
| (616) 267-8244 | |
| Not Available |
| Full Name | Dr Disha Geriani |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 9 Years |
| Location | 4100 Lake Dr Se Ste 200, Grand Rapids, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942652961 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 4301500302 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southwestern Vermont Medical Center | Bennington, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southwestern Vermont Medical Center Inc | 0143138446 | 142 |
News Archive
A team of scientists from Brazil recently explored the abilities of the UK, South African, and Brazilian variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to evade host CD8+ T cell responses induced by natural infection or vaccination. The findings reveal reduced antigenic coverage for the P.2 Brazilian lineage, indicating its ability to evade SARS-CoV-2-induced T cell responses.
Poor or declining handgrip strength in the oldest old is associated with poor survival and may be used as a tool to assess mortality, found an article in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj091278.pdf. The fastest growing segment of the elderly population is the group older than 85 years, classified as the oldest old.
America's cities face a looming water crisis, driven by climate change, growing population and a crumbling infrastructure. Recognizing the critical importance of this issue, the National Science Foundation has selected a partnership of four U.S. universities to form an Engineering Research Center (ERC) to address this challenge by developing new, sustainable ways to manage urban water.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced favorable response and safety indications from a group of patients with advanced solid tumors (principally soft tissue sarcomas) in the Company's ongoing Phase 1b/2 clinical trial with INNO-206, its tumor-targeting conjugate of the commonly used chemotherapeutic agent doxorubicin.
› Verified 3 days ago
| Entity Name | Southwestern Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184994162 PECOS PAC ID: 0143138446 Enrollment ID: O20120613000217 |
News Archive
A team of scientists from Brazil recently explored the abilities of the UK, South African, and Brazilian variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to evade host CD8+ T cell responses induced by natural infection or vaccination. The findings reveal reduced antigenic coverage for the P.2 Brazilian lineage, indicating its ability to evade SARS-CoV-2-induced T cell responses.
Poor or declining handgrip strength in the oldest old is associated with poor survival and may be used as a tool to assess mortality, found an article in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj091278.pdf. The fastest growing segment of the elderly population is the group older than 85 years, classified as the oldest old.
America's cities face a looming water crisis, driven by climate change, growing population and a crumbling infrastructure. Recognizing the critical importance of this issue, the National Science Foundation has selected a partnership of four U.S. universities to form an Engineering Research Center (ERC) to address this challenge by developing new, sustainable ways to manage urban water.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced favorable response and safety indications from a group of patients with advanced solid tumors (principally soft tissue sarcomas) in the Company's ongoing Phase 1b/2 clinical trial with INNO-206, its tumor-targeting conjugate of the commonly used chemotherapeutic agent doxorubicin.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Disha Geriani, MD 4100 Lake Dr Se Ste 200, Grand Rapids, MI 49546-8292 Ph: () - | Dr Disha Geriani, MD 4100 Lake Dr Se Ste 200, Grand Rapids, MI 49546-8292 Ph: (616) 267-8244 |
News Archive
A team of scientists from Brazil recently explored the abilities of the UK, South African, and Brazilian variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to evade host CD8+ T cell responses induced by natural infection or vaccination. The findings reveal reduced antigenic coverage for the P.2 Brazilian lineage, indicating its ability to evade SARS-CoV-2-induced T cell responses.
Poor or declining handgrip strength in the oldest old is associated with poor survival and may be used as a tool to assess mortality, found an article in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj091278.pdf. The fastest growing segment of the elderly population is the group older than 85 years, classified as the oldest old.
America's cities face a looming water crisis, driven by climate change, growing population and a crumbling infrastructure. Recognizing the critical importance of this issue, the National Science Foundation has selected a partnership of four U.S. universities to form an Engineering Research Center (ERC) to address this challenge by developing new, sustainable ways to manage urban water.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced favorable response and safety indications from a group of patients with advanced solid tumors (principally soft tissue sarcomas) in the Company's ongoing Phase 1b/2 clinical trial with INNO-206, its tumor-targeting conjugate of the commonly used chemotherapeutic agent doxorubicin.
› Verified 3 days ago
Maureen U Tan- Pedres, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 100 Michigan St Ne, Suite A721, Grand Rapids, MI 49503 Phone: 616-391-3139 Fax: 616-391-3044 | |
Jeffery Allen Woo, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1900 Wealthy St Se, Ste 150, Grand Rapids, MI 49506 Phone: 616-459-3158 Fax: 616-988-0071 | |
Robert W Selfe, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 221 Michigan St Ne, Suite 200, Grand Rapids, MI 49503 Phone: 616-267-8950 Fax: 616-267-8585 | |
Dr. Erin Megan Pettijohn, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 250 Cherry St Se Ste 2200, Grand Rapids, MI 49503 Phone: 616-685-5600 | |
Dr. Andrew Leo Sochacki, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5800 Foremost Dr Se Ste 200, Grand Rapids, MI 49546 Phone: 616-389-1800 | |
Stephanie F Williams, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 145 Michigan St Ne, Suite 5200, Grand Rapids, MI 49503 Phone: 616-486-5933 Fax: 616-486-6489 | |
Simin Beg, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 145 Michigan St Ne Ste 3410, Grand Rapids, MI 49503 Phone: 616-391-9945 |